Form 8.5 (EPT/NON-RI) (8055Z)
20 1월 2011 - 8:45PM
UK Regulatory
TIDMBII
RNS Number : 8055Z
Nomura Code Securities Limited
20 January 2011
FORM 8.5 (EPT/NON-RI)
DEALING DISCLOSURE BY AN
EXEMPT PRINCIPAL TRADER WITHOUT RECOGNISED INTERMEDIARY ("RI")
STATUS (OR WHERE RI STATUS IS NOT APPLICABLE)
Rule 8.5 of the Takeover Code (the "Code")
1. KEY INFORMATION
(a) Name of exempt principal trader: Nomura Code Securities Limited
(b) Name of offeree in relation to Biocompatibles International plc
whose relevant securities this form
relates:
---------------------------------
(c) Name of the party to the offer Biocompatibles International plc
with which exempt principal trader is
connected:
---------------------------------
(d) Date position held/dealing 19 January 2011
undertaken:
---------------------------------
(e) Has the EPT previously disclosed, Yes
or is it today disclosing, under the
Code in respect of any other party to
this offer?
---------------------------------
2. POSITIONS OF THE EXEMPT PRINCIPAL TRADER
(a) Interests and short positions in the relevant securities of
the offeror or offeree to which the disclosure relates following
the dealing (if any)
Class of relevant security:
Interests Short positions
-------------- ------------------
Number % Number %
-------- ---- ------------- ---
(1) Relevant securities owned and/or
controlled: 158,505 0.4
-------- ---- ------------- ---
(2) Derivatives (other than options):
-------- ---- ------------- ---
(3) Options and agreements to
purchase/sell:
-------- ---- ------------- ---
TOTAL: 158,505 0.4
-------- ---- ------------- ---
(b) Rights to subscribe for new securities (including directors'
and other executive options)
Class of relevant security in relation to which subscription
right exists:
Details, including nature of the rights concerned
and relevant percentages:
3. DEALINGS (IF ANY) BY THE EXEMPT PRINCIPAL TRADER
(a) Purchases and sales
Class of relevant Number of
security Purchase/sale securities Price per unit
Ordinary Shares Sale 5,000 400 p
--------------- -------------------- ---------------
Total Sales 5,000
-------------------- ---------------
(b) Derivatives transactions (other than options)
Class of Product Nature of dealing Number of Price per
relevant description e.g. reference unit
security e.g. CFD opening/closing a securities
long/short
position,
increasing/reducing
a long/short
position
(c) Options transactions in respect of existing securities
(i) Writing, selling, purchasing or varying
Class of Product Writing, Number of Exercise Type e.g. Expiry Option
relevant description purchasing, securities price American, date money
security e.g. call selling, to which per European paid/
option varying option unit etc. received
etc. relates per
unit
(ii) Exercising
Class of relevant Product Number of Exercise price
security description e.g. securities per unit
call option
(d) Other dealings (including subscribing for new
securities)
Class of relevant Nature of dealing Details Price per unit (if
security e.g. subscription, applicable)
conversion
4. OTHER INFORMATION
(a) Indemnity and other dealing arrangements
Details of any indemnity or option arrangement, or
any agreement or understanding, formal or informal,
relating to relevant securities which may be an inducement
to deal or refrain from dealing entered into by the
exempt principal trader making the disclosure and
any party to the offer or any person acting in concert
with a party to the offer:
If there are no such agreements, arrangements or understandings,
state "none"
None
(b) Agreements, arrangements or understandings relating to
options or derivatives
Details of any agreement, arrangement or understanding,
formal or informal, between the exempt principal trader
making the disclosure and any other person relating
to:
(i) the voting rights of any relevant securities under
any option; or
(ii) the voting rights or future acquisition or disposal
of any relevant securities to which any derivative
is referenced:
If there are no such agreements, arrangements or understandings,
state "none"
None
(c) Attachments
Is a Supplemental Form 8 (Open Positions) attached? NO
Date of disclosure: 20 January 2011
Contact name: Niall Campbell
----------------
Telephone number: 020 7776 1226
----------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
FEOURURRAVAAUAR
Biocompatibles (LSE:BII)
과거 데이터 주식 차트
부터 5월(5) 2024 으로 6월(6) 2024
Biocompatibles (LSE:BII)
과거 데이터 주식 차트
부터 6월(6) 2023 으로 6월(6) 2024
